# Gencor Industries Inc: Form 10-Q for the period ended Dec 31, 2024

- Company: [Gencor Industries Inc](/companies/genc.md) (CIK 64472)
- Form: 10-Q
- Filed: 2025-07-25
- Accepted by EDGAR: Jul 25, 2025, 07:30 ET
- Period: 2024-12-31
- Accession: 0001193125-25-164836
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/64472/000119312525164836/d849445d10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/64472/000119312525164836/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2024-10-01 to 2024-12-31 | $31.4m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months, 2024-10-01 to 2024-12-31 | $22.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2024-10-01 to 2024-12-31 | $8.7m | us-gaap:GrossProfit |
| Research and development | 3 months, 2024-10-01 to 2024-12-31 | $677.0k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2024-10-01 to 2024-12-31 | $3.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2024-10-01 to 2024-12-31 | $4.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2024-10-01 to 2024-12-31 | $1.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2024-10-01 to 2024-12-31 | $3.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2024-10-01 to 2024-12-31 | $0.26 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2024-10-01 to 2024-12-31 | $0.26 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2024-10-01 to 2024-12-31 | 14,658,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2024-10-01 to 2024-12-31 | $14.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2024-10-01 to 2024-12-31 | $319.0k | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | at 2024-12-31 | $40.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $203.1m | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $218.2m | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $16.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $18.2m | us-gaap:Liabilities |
| Shareholders' equity | at 2024-12-31 | $200.0m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/64472/000119312525164836/d849445d10q.htm

Filed Jul 25, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-164836. Last ingested by Listed: Oct 24, 2026, 14:53 ET. No prices; not investment advice.
